RVNC — Revance Therapeutics Share News
0.000.00%
Last trade - 00:00- $379.98m
- $637.94m
- $234.04m
Revance Therapeutics Inc expected to post a loss of 75 cents a share - Earnings Preview
Revance Therapeutics Inc expected to post a loss of 75 cents a share - Earnings Preview
AbbVie lifts profit forecast after Skyrizi sales beat expectations (updated)
AbbVie raises annual profit forecast on strong Skyrizi sales
U.S. STOCKS ON THE MOVE-Akero Therapeutics, Vista Outdoor, Sea
U.S. STOCKS ON THE MOVE-Super Micro, Decker, Rumble
Revance Therapeutics drops after $100 mln stock offering prices
U.S. STOCKS ON THE MOVE-Avidity, C4 Therapeutics, Avadel Pharma
Brief: Revance Prices $100 Mln Public Offering
Revance Therapeutics drops on $100 mln stock offering plans
Brief: Revance Announces Proposed Public Offering Of Common Stock
U.S. RESEARCH ROUNDUP-Okta, Salesforce, Sarepta Therapeutics
Revance Therapeutics Inc reports results for the quarter ended in December - Earnings Summary
Brief: Revance Therapeutics Q4 EPS USD -0.62
Revance Therapeutics Inc expected to post a loss of 72 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Edwards Lifesciences, Deckers, Regeneron
Revance Therapeutics up on receiving billing code for dystonia injection
U.S. STOCKS ON THE MOVE-Sarepta, Hershey, Dollar Tree
U.S. STOCKS ON THE MOVE-Overseas Shipholding, Palisade Bio, Archer-Daniels-Midland